Executive Management

BILL W. MASSEY, PHD

QUALIFICATIONS PROFILE

Remarkably astute, tenacious, and seasoned senior executive offering more than 15 years of experience in Sales, Marketing, International Business Development, R&D, and Operations. Demonstrates competency in directing highly profitable businesses and leading consultative and technical services for the pharmaceutical and life sciences industries. Possesses stellar reputation in establishing and implementing effective strategies and plans coupled with recognized ability in improving efficiency and productivity. Strong background utilizing out-of-the-box approaches in training and developing employees to foster team unity toward achievement of corporate goals and objectives. Extremely able to multitask in fiercely competitive, team-oriented, and fast-paced situations with dedication to superior service.

CORE COMPETENCIES

- Business Management and Operations

- Return on Investment Analysis

- Leadership, Training, and Team Building

- Quality Control and Regulatory Compliance

- Outstanding Customer Service and Relations

- Marketing Strategies and Campaigns

- Territory and Account Management

- Sales Action Plans and Development

- Problem Resolution and Decision Making

- Continuous Process Improvement

- Strong Analytical and Interpersonal Skills

- Articulate Oral and Written Communication

EMPLOYMENT HISTORY

PRESIDENT / CHIEF EXECUTIVE OFFICER 2006–PRESENT

B.W. MASSEY & COMPANY INC. - HEBER SPRINGS, AR AND RAMONA, CA

- Direct and coordinate daily operational business aspects that offer executive, consultative, and technical services for the pharmaceutical and life sciences industries

- Establish and implement organizational policies, process and procedures to achieve corporate goals and objectives

- Build and cultivate positive working attitude to foster team unity and ensure the highest level of staff performance

PRESIDENT 2006–PRESENT

LITMUS MOLECULAR DESIGN, LLC - RAMONA, CA

- Provided expert oversight, advice, and guidance to corporate operations for drug discovery technology start-up

- Instrumental in designing and patenting 259 new chemical entities for multi-billion dollar markets

- Skyrocketed asset portfolio to more than $30 million in NCEs on shoestring budget, excluding new inventions or other asset value increases

- Developed FDA-licensed technology and dramatically improved efficiency and predictive accuracy, while substantially reducing the time and costs of commercialization of new molecular entities

ADJUNCT ASSISTANT PROFESSOR 1995–PRESENT

DEPARTMENT OF PHARMACOLOGY AND TOXICOLOGY, THE UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES - LITTLE ROCK, AR

- Active participant in medical school faculty in teaching of medical and graduate students

- Regularly communicated with students and colleagues in teaching course and clinical material and in the achievement of identified learning goals

CLINICAL ASSISTANT PROFESSOR 1993–PRESENT

DEPARTMENT OF PSYCHIATRY AND HUMAN BEHAVIOR, THE UNIVERSITY OF MISSISSIPPI MEDICAL CENTER - JACKSON, MS

- Initiated the development of instructional materials and student learning activities for drug development lectures based on program and course objectives and within the context of the program's philosophy

- Presented theory and clinical instruction to provide an optimal learning environment for students

FOUNDER / MANAGING PARTNER 2001–2006

SCIENTIFIC COMMERCIALIZATION LLC - PHOENIXVILLE, PA

- Presided over in all areas of a start-up consulting agency that was grown into a successful nationwide multi-million dollar revenue-producing business

- Responsible for selling 48% equity stake in 2006

- Supported clients to achieve their business objectives by providing innovative solutions that optimize the development, registration, and commercialization of their products

PRESIDENT / CHIEF OPERATING OFFICER 2002–2004

ARCTOS PHARMACEUTICALS, INC. - ANCHORAGE, AK

- Displayed unsurpassed leadership in an Anchorage-based start-up company formed to search for Alaska plants and other organisms with medicinal properties

- Supervised natural-source biopharmaceutical company operations to optimize efficiency

GROUP DIRECTOR, BUSINESS OPERATIONS, MEDICAL AFFAIRS 2000–2001

ASTRAZENECA LP - WAYNE, PA

- Played a vital role in completing the U.S. integration and implementation of new operating model

- Conceptualized and validated new business model for Field-Based Medical Programs

- Spearheaded the Sales Force Optimization Team responsible for integrating metrics designed for the new business model into the Sales Operations business planning model

- Senior Leadership Team that made strategic decisions related to the skill center’s activities

- Diligently managed the geographic-based MSL territory reconfiguration project and developed routine operating processes and systems

- Assumed responsibilities in maintaining routine operating processes and business metrics analyses

SENIOR DIRECTOR 2000

STRATEGIC DEVELOPMENT, PSYCHIATRY & NEUROLOGY, SCIREX CORPORATION - SAN DIEGO, CA

- Solidified long-term quality relationship with domestic and international clients to provide total satisfaction as well as to generate repeat business and referrals

- Convened with potential sponsor to address their needs with various departments within SCIREX

- Formulated effective marketing strategies by utilizing therapeutic expertise

- Worked collaboratively with executive management on projections / plans for new business

SENIOR DIRECTOR, CNS THERAPEUTICS 1999–2000

QUINTILES REGULATORY & TECHNICAL SERVICES, QUINTILES PACIFIC, INC. - SAN DIEGO, CA

- Regarded as Scientific Leader of CNS regulatory and consultation services group within the regulatory business unit

- Ensured quality of regulatory liaison services, regulatory submissions preparation (IND, NDA, SNDA), technical consultation, technical reports, medical writing, strategic development plans, early-phase development consultation and regulatory maintenance

- Directed product development programs ranging in the $100 millions

- Took part in Executive Management Team responsible in making profit center decisions and governance

EARLIER CAREER

Quintiles CNS Therapeutics, Quintiles Pacific, Inc., San Diego, CA

- SENIOR SCIENTIST, CNS DRUG DEVELOPMENT: 1998–1999

- DIRECTOR, STRATEGIC SCIENTIFIC AND BUSINESS PLANNING: 1997–1998

Astra Merck, Incorporated Wayne, PA / Memphis, TN

- DIRECTOR-REGULATORY AFFAIRS, CNS, 1996–1997

- BUSINESS MANAGER: 1995–1996

- MEDICAL INFORMATION SCIENTIST: 1993–1994

> Received the Astra Merck Special Achievement Award, “Successful Documentation and Publication of the Candesartan Cilexetil NDA for Hypertension:” 1997

> Achieved the Astra Merck Award of Excellence, “Targeting Workshop:” 1996

> btained the Astra Merck Award of Excellence, “Preparation of the First Astra Merck Original Investigational New Drug Application:” 1995

Department of Pharmacological and Physiological Sciences, The University of Chicago, Pritzker School of Medicine, Chicago, IL

- RESEARCH ASSOCIATE: 1991–1992

EDUCATION

DOCTOR OF PHILOSOPHY IN PHARMACOLOGY

- University of Arkansas for Medical Sciences, Little Rock, AR: 1991

President of the Graduate Student Association: 1989–1990

Graduate Assistantship, University of Arkansas for Medical Sciences: 1986–1990

Achieved the Young Investigator Travel Award, National Center for Toxicological Research, to attend the Methods in Behavioral Toxicology/Teratology meeting, Little Rock, Arkansas: 1989

Treasurer of the Graduate Student Association: 1987–1988

Completed the Biology Honors Project entitled “Effects of Body Weight on the Discriminative Stimulus Properties of Phencyclidine” under the supervision of Donald E. McMillan: 1985

Recipient of Graduate Student Travel Award, American Society for Pharmacology and Experimental Therapeutics to attend the 41st Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics, Milwaukee, Wisconsin: 1990

BACHELOR OF SCIENCE IN BIOLOGY

- University of Central Arkansas, Conway, AR: 1986

Gamma Beta Phi Honor Society, University of Central Arkansas: 1985–1986

Dean’s List and President’s List: 1985

ZOOLOGY PROGRAM

- University of Arkansas, Fayetteville, AR: 1983

Dean’s List: 1983

CONTINUING EDUCATION

- Cortico-Basal Degeneration Course, International Symposium on Parkinson’s Disease, London, England: 1997

- Animal Models Course, International Symposium on Parkinson’s Disease, London, England: 1997

- The Management Development Program in Health Care, Center of Excellence in Health Care Management, University of Southern California, Los Angeles, CA: 1995

PROFESSIONAL AFFILIATIONS

- Member, American Academy of Neurology: 1996–Present

- Member, American Neuropsychiatric Association: 1993–Present

- Member, American Association for the Advancement of Science: 1989–1992

- Member, American Heart Association, Council on Basic Science: 1993-1995

- Member, American Society for Pharmacology and Experimental Therapeutics: 1986–1997

- Member, College on the Problems of Drug Dependence: 1991–1992

- Member, Drug Information Association: 1996–1999

- Member, Hypertension Optimal Treatment International Study, Clinical Study Monitor: 1993–1994

- Member, Society for Neuroscience: 1986–2007

- Member, Society for the Stimulus Properties of Drugs: 1990–1992

Contact this candidate